OncoMatch/Clinical Trials/NCT07814014
Real-world Insight Into Systemic Therapies for HCC: Single-center Study
Official title: Real-world Insight Into Systemic Therapies for Hepatocellular Carcinoma: a Comprehensive Single-center Study
Is NCT07814014 recruiting? Yes, currently enrolling (Oct 2026).
Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies
Check if I qualifyExtracted eligibility criteria
Cancer type
Hepatocellular Carcinoma
Disease stage
Required: Stage BCLC STAGE C, BCLC STAGE B WITH DIFFUSE, INFILTRATIVE OR EXTENSIVE BILOBAR INVOLVEMENT, BCLC STAGE B WITH TUMOR PROGRESSION AFTER TACE (other)
Barcelona Clinic Liver Cancer (BCLC) stage C or BCLC stage B with diffuse, infiltrative or extensive bilobar involvement or BCLC stage B with tumor progression after TACE
Performance status
ECOG 0–1(Restricted strenuous activity)
Lab requirements
Liver function
child-pugh class a, b7
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07814014 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage BCLC STAGE C or BCLC STAGE B WITH DIFFUSE, INFILTRATIVE OR EXTENSIVE BILOBAR INVOLVEMENT or BCLC STAGE B WITH TUMOR PROGRESSION AFTER TACE is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages